Pemazyre (pemigatinib)

pCPA File Number: 21817
Negotiation Status:
Under consideration for negotiation
Indication(s):
adults with previously treated, unresectable locally advanced or metastatic CCA with a FGFR2 fusion or other rearrangement
Sponsor/Manufacturer:
Incyte Biosciences Canada Corporation
CADTH Project Number:
PC0252
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable